Hospitals Scramble as Antibody Treatments Fail Against Omicron

By BY CHRISTINA JEWETT, CARL ZIMMER AND REBECCA ROBBINS from NYT Health
https://ift.tt/32c63fc
The single remaining monoclonal antibody therapy effective against the variant is now in short supply in the U.S., imperiling an option that doctors and hospitals have relied on.